About Radicool Pharmaceutical Private Limited
Data last updated:
Radicool Pharmaceutical Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 January 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51101DL2014PTC263647. Its GSTIN is 07AAGCR7869B1Z4 (Delhi).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹77 Lakh. It is led by directors Beena Rawat and Lalit Singh.
Its last annual general meeting (AGM) was held on 19 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 154 First Floor Dda Shed Okhla Phase – 1 Industrial Area, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.23 Cr. For the same year it recorded a net profit of ₹19.95 Lakh (net margin 2.2%) and EBITDA of ₹60.09 Lakh (EBITDA margin 6.5%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 4% over five years.
The company has about 21 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹7.66 Cr and satisfied charges of ₹1.53 Cr on record. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website radicoolpharmaceutical.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressB – 154 First Floor Dda Shed Okhla Phase – 1 Industrial Area, New Delhi, Delhi, India – 110020
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Radicool Pharmaceutical Private Limited
The main business activity of Radicool Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Radicool Pharmaceutical Private Limited FY 2025 filings available
Radicool Pharmaceutical Private Limited reported revenue of ₹9.23 Cr for FY 2025.
Compounded Annual Growth Rate (CAGR) of Radicool Pharmaceutical Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Radicool Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹60.09 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹19.95 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Radicool Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Radicool Pharmaceutical are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Radicool Pharmaceutical Private Limited
Radicool Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Idealife Healthcare Limited | ₹9.32 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Kanpur, Uttar Pradesh, India |
| Palmo Industrial Silicones Private Limited | ₹9.32 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Vadodara, Gujarat, India |
| Bohra Lifescience Private Limited | ₹9.28 Cr (FY 2024) | •••• | •••• | 115.0% | •••• | Mumbai, Maharashtra, India |
| Poddar Pharmaceuticals Private Limited | ₹9.25 Cr (FY 2024) | •••• | •••• | 83.0% | •••• | Uttar Pradesh, India |
| Thio Chemi Private Limited | ₹9.24 Cr (FY 2025) | •••• | •••• | 55.0% | •••• | Coimbatore, Tamil Nadu, India |
| Radicool Pharmaceutical Private Limited this company | ₹9.23 Cr (FY 2025) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Dorizoe Lifesciences Limited | ₹9.23 Cr (FY 2017) | •••• | •••• | 21.0% | •••• | Ahmedabad, Gujarat, India |
| Daeiou Pharmaceuticals Private Limited | ₹9.23 Cr (FY 2023) | •••• | •••• | 3.0% | •••• | Puducherry, India |
| Future Pharma Private Limited | ₹9.22 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Kanpur, Uttar Pradesh, India |
| Gloss Pharmaceuticals Private Limited | ₹9.22 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Uttar Pradesh, India |
| Elegant Chemical Enterprises Pvt Ltd | ₹9.21 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Radicool Pharmaceutical by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Radicool Pharmaceutical Private Limited
Radicool Pharmaceutical Private Limited is audited by M P & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M P & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Radicool Pharmaceutical Private Limited
Radicool Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Beena Rawat | Director | 16 Jan 2014 | 12 Years 8 Months | Current |
| Lalit Singh Also directs: Abetar Healthcare Private Limited | Director | 16 Jan 2014 | 12 Years 8 Months | Current |
Ownership and Shareholding of Radicool Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Radicool Pharmaceutical Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Dec 2024 | Others | ₹9 Lakh | Open |
| 10 Dec 2024 | Others | ₹9 Lakh | Open |
| 21 Jun 2024 | Axis Bank Limited | ₹1.77 Cr | Open |
| 12 Oct 2023 | Others | ₹9.95 Lakh | Open |
| 22 Aug 2023 | Axis Bank Limited | ₹1.53 Cr | Open |
Total charge records: 10 View all charges
Legal Cases of Radicool Pharmaceutical Private Limited
Radicool Pharmaceutical Private Limited has 1 court case on record: 1 filed against it. All case is disposed. Status as checked on 01 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, East, Delhi | Civil suit | Filed against the company by State | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Radicool Pharmaceutical Private Limited
Radicool Pharmaceutical Private Limited has a workforce of 21 employees as of Mar 30, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Radicool Pharmaceutical Private Limited
Radicool Pharmaceutical Private Limited has 2 board changes on record since 2014: 2 appointments. The latest: Beena Rawat was appointed as Director on 16 Jan 2014.
4 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Radicool Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Radicool Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Radicool Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Radicool Pharmaceutical Private Limited
Radicool Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAGCR7869B1Z4 | Delhi | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Radicool Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Radicool Pharmaceutical Private Limited
Radicool Pharmaceutical is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 January 2014 (12+ years old) and is registered under CIN U51101DL2014PTC263647.
Radicool Pharmaceutical reported revenue of ₹9.23 Cr for FY 2025.
Radicool Pharmaceutical has 2 current directors:
- Beena Rawat - Director
- Lalit Singh - Director
Radicool Pharmaceutical reported a net profit of ₹19.95 Lakh (net margin 2.2%) and EBITDA of ₹60.09 Lakh (EBITDA margin 6.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Radicool Pharmaceutical is 21% over three years and 4% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Radicool Pharmaceutical is 07AAGCR7869B1Z4, registered in Delhi.
The CIN (Corporate Identification Number) of Radicool Pharmaceutical is U51101DL2014PTC263647. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Radicool Pharmaceutical has 1 court case on record: 1 filed against it.
Radicool Pharmaceutical was incorporated on 16 January 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Radicool Pharmaceutical by revenue are Idealife Healthcare Limited, Palmo Industrial Silicones Private Limited, Bohra Lifescience Private Limited, Poddar Pharmaceuticals Private Limited, Thio Chemi Private Limited and 5 more, all in the Pharma industry (Formulations).
Beena Rawat was appointed as Director on 16 Jan 2014. Lalit Singh was appointed as Director on 16 Jan 2014.